focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Broker tips: Next, Tullow, British American Tobacco...

Wed, 30th Apr 2014 13:27

Shares in Next are up with events, according to Investec, despite a better-than-expected first-quarter update and raised guidance from the high street retail group on Wednesday."We view Next as a core holding, but with the shares trading on a sector average price-to-earnings rating, we believe the valuation is up with events and retain our 'hold' recommendation."Prime Wealth Group has labelled Tullow Oil as a 'buy', saying that Wednesday's production update and asset sales mark a 'turning point' for the shares."Tullow Oil shares have effectively been falling steadily since mid 2012 highs around 1,500p, as unsuccessful drilling campaigns and other hitches put an end to a long bull run for the explorer. Today however, most of the uncertainty has been removed by the sale of the Schooner and Ketch gas fields, enabling the group to redouble focus on its Kenya successes, and put the group on a strong financial footing."Panmure Gordon has upgraded British American Tobacco (BAT) from 'hold' to 'buy', saying it sees an improving performance in the second half from the company. The broker has hiked its target price for the stock from 3,225p to 3,850p."During the second half, currency headwinds are likely to ease in and pricing should accelerate contributing good underlying earnings growth."Analysts predict BSkyB's new broadband customer numbers will fall around 50% in the third quarter, as the company's battle with BT takes a continuing toll. The media group is due to report its results for the three months to the end of March on Thursday.Analysts at Deutsche Bank and Morgan Stanley (MS) respectively forecast broadband additions of 80,000 and 70,000, down from 152,000 in the same quarter last year and compared to 110,000-119,000 in the last three quarters. Credit Suisse has reiterated its 'overweight' position on the big-cap pharmaceuticals sector, saying that 25% of M&A deals in the year to date have been from the sector. "From a macro perspective, drugs have the best combination of low leverage (thus outperform if the US cost of debt rises), dollar earners (we are dollar bulls) and low global emerging market (GEM) exposure (22%) within defensives - and unlike staples GEM exposure trades on a discount to developed markets."BC

Related Shares

More News
20 May 2024 09:47

LONDON BROKER RATINGS: Deutsche likes Trainline and Baltic Classifieds

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

16 May 2024 16:29

EARNINGS AND TRADING: Tullow Oil on track to hit free cash flow target

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

16 May 2024 09:57

LONDON BROKER RATINGS: Barclays raises Travis Perkins to 'overweight'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

16 May 2024 09:13

Tullow Oil on track to hit production and cash flow guidance

(Sharecast News) - Tullow Oil has said it's on track to deliver full-year guidance and remains well placed to capitalise on a higher oil-price environ...

9 May 2024 15:51

UK earnings, trading statements calendar - next 7 days

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.